Table 3.
Reporting criterion | JIF |
CONSORT endorsement status |
||||
---|---|---|---|---|---|---|
Odds ratio per doubling JIF | P | 95% Confidence interval | Odds ratio | P | 95% Confidence interval | |
MD reporting criteria | ||||||
Account for all participantsa | 1.54 | 0.001 | 1.20–1.97 | 2.46 | 0.1 | 0.73–8.23 |
Report number of participants not included in the primary outcome analysisa | 1.39 | 0.001 | 1.15–1.69 | 1.20 | 0.8 | 0.31–4.70 |
Report reasons for MDa,b | 0.88 | 0.5 | 0.63–1.23 | 0.65 | 0.5 | 0.20–2.17 |
Report plans to minimize MD | 1.16 | 0.17 | 0.94–1.42 | 1.00 | 1.00 | 0.40–2.49 |
Compare baseline characteristics of participants with and without MD | 1.50 | <0.001 | 1.20–1.87 | 1.11 | 0.83 | 0.42–2.92 |
Report methods used to handle MD | 1.40 | 0.002 | 1.13–1.73 | 2.53 | 0.03 | 1.08–5.94 |
Report MD sensitivity analyses | 1.20 | 0.4 | 0.81–1.80 | 3.48 | 0.03 | 1.15–10.50 |
Discuss impact of MD on the interpretation of findings | 1.14 | 0.2 | 0.93–1.41 | 1.85 | 0.1 | 0.85–4.04 |
Other CONSORT 2010 risk of bias reporting criteria | ||||||
Report method of sequence generationa | 1.09 | 0.2 | 0.94–1.26 | 1.79 | 0.2 | 0.79–4.03 |
Report method of allocation sequence concealmenta | 1.29 | 0.01 | 1.06–1.57 | 2.03 | 0.2 | 0.36–6.55 |
Report blinding participants & personnela | 1.09 | 0.2 | 0.96–1.25 | 1.32 | 0.6 | 0.51–3.41 |
Report method of blinding outcome assessmenta | 1.04 | 0.5 | 0.91–1.19 | 1.41 | 0.5 | 0.55–3.62 |
Abbreviations: MD, missing data; CONSORT, the Consolidated Standards of Reporting Trials; JIF, journal impact factor.
CONSORT 2010 recommendation.
Assessed as whether they reported any reasons for MD.